Prevalence and levels in serum and cerebrospinal fluid (CSF) from cNPSLE patients, as determined at baseline and 6 months. Values are expressed sa median (min-max).
| cNPSLE, Baseline, n = 23 | cNPSLE, 6 mo, n = 23 | p | |
|---|---|---|---|
| Serum | |||
| S100B levels* | 24.6 (19.8–164.3) | 24.6 (12.6–55.3) | 0.19 |
| S100B-positive (%) | 4 (17) | 1 (4) | 0.35 |
| S100B levels** | 65.7 (48–164.3) | 29.7 (22.8–55.3) | 0.07 |
| CSF | |||
| SB100 levels* | 265.4 (68.9–2500) | 154.2 (65.5–525.8) | 0.004 |
| S100B-positive (%) | 7 (30) | 0 | 0.009 |
| S100B levels** | 2325.7 (535.4–2500) | 130.2 (65.5–256.9) | 0.02 |